Gender- and Age-Specific Associations Between Body Fat Composition and C-Reactive Protein with Lung Function: A Cross-Sectional Study

Overview

Journal Sci Rep

Specialty Science

Date 2019 Jan 25

PMID 30674938

Citations 6

Authors

Yu-Chung Tsao

Yi-Yen Lee

Jau-Yuan Chen

Wei-Chung Yeh

Chung-Hsun Chuang

Wei Yu

Wen-Cheng Li

Affiliations

Soon will be listed here.

Abstract

Lung function deterioration is frequently observed in overweight and obese patients. In the current study, we explored the contribution of body fat (BF) composition, particularly visceral and nonvisceral adiposity, to lung function deterioration. In addition, we examined gender- and age-specific differences in the association between the joint effects of BF% and C-reactive protein (CRP) concentrations with lung function. This cross-sectional study involved 17,802 subjects undergoing health check-up. Clinical characteristics, body composition using bioelectrical impedance analysis (BIA), and lung function were evaluated and compared between genders. Subjects were stratified by gender-specific BF% cut-offs for evaluating the association of body composition and the risk of restrictive lung disease (RLD). Gender differences in the joint effects of BF% and CRP on lung function were observed. Visceral obesity increased the risk of RLD in women aged ≥45 years, but nonvisceral obesity reduced the risk of RLD in women aged <45 years. Our findings suggest that visceral fat per se can be used as an effective parameter to assess the association between lung function and obesity.

Citing Articles

Genetic correlation and causal relationships between cardio-metabolic traits and lung function impairment.

Wielscher M, Amaral A, van der Plaat D, Wain L, Sebert S, Mosen-Ansorena D Genome Med. 2021; 13(1):104.

PMID: 34154662 PMC: 8215837. DOI: 10.1186/s13073-021-00914-x.

Causal Effects of Body Mass Index on Airflow Obstruction and Forced Mid-Expiratory Flow: A Mendelian Randomization Study Taking Interactions and Age-Specific Instruments Into Consideration Toward a Life Course Perspective.

Probst-Hensch N, Jeong A, Stolz D, Pons M, Soccal P, Bettschart R Front Public Health. 2021; 9:584955.

PMID: 34046380 PMC: 8144328. DOI: 10.3389/fpubh.2021.584955.

Comparison of body composition parameters in the study of the association between body composition and pulmonary function.

Ishikawa C, Barbieri M, Bettiol H, Bazo G, Ferraro A, Vianna E BMC Pulm Med. 2021; 21(1):178.

PMID: 34034727 PMC: 8146631. DOI: 10.1186/s12890-021-01543-1.

Association of obesity-related inflammatory pathways with lung function and exercise capacity.

McNeill J, Lau E, Zern E, Nayor M, Malhotra R, Liu E Respir Med. 2021; 183:106434.

PMID: 33964816 PMC: 8144063. DOI: 10.1016/j.rmed.2021.106434.

Visceral Fat Area, Not Subcutaneous Fat Area, is Associated with Cardiac Hemodynamics in Type 2 Diabetes.

Qiu Y, Deng X, Sha Y, Wu X, Zhang P, Chen K Diabetes Metab Syndr Obes. 2020; 13:4413-4422.

PMID: 33235479 PMC: 7680090. DOI: 10.2147/DMSO.S284420.

References

Yudkin J, Stehouwer C, Emeis J, Coppack S . C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 1999; 19(4):972-8. DOI: 10.1161/01.atv.19.4.972. View

Womack C, Harris D, Katzel L, Hagberg J, Bleecker E, Goldberg A . Weight loss, not aerobic exercise, improves pulmonary function in older obese men. J Gerontol A Biol Sci Med Sci. 2000; 55(8):M453-7. DOI: 10.1093/gerona/55.8.m453. View

Wener M, Daum P, McQuillan G . The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol. 2000; 27(10):2351-9. View

Santana H, Zoico E, Turcato E, Tosoni P, Bissoli L, Olivieri M . Relation between body composition, fat distribution, and lung function in elderly men. Am J Clin Nutr. 2001; 73(4):827-31. DOI: 10.1093/ajcn/73.4.827. View

Blaak E . Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care. 2001; 4(6):499-502. DOI: 10.1097/00075197-200111000-00006. View

Van Pelt R, Evans E, Schechtman K, Ehsani A, Kohrt W . Contributions of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab. 2002; 282(5):E1023-8. DOI: 10.1152/ajpendo.00467.2001. View

Tanko L, Bagger Y, Alexandersen P, Larsen P, Christiansen C . Central and peripheral fat mass have contrasting effect on the progression of aortic calcification in postmenopausal women. Eur Heart J. 2003; 24(16):1531-7. DOI: 10.1016/s0195-668x(03)00319-1. View

Flier J . Obesity wars: molecular progress confronts an expanding epidemic. Cell. 2004; 116(2):337-50. DOI: 10.1016/s0092-8674(03)01081-x. View

Danesh J, Wheeler J, Hirschfield G, Eda S, Eiriksdottir G, Rumley A . C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004; 350(14):1387-97. DOI: 10.1056/NEJMoa032804. View

10.

Gan W, Man S, Senthilselvan A, Sin D . Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004; 59(7):574-80. PMC: 1747070. DOI: 10.1136/thx.2003.019588. View

11.

Cevrioglu A, Fidan F, Unlu M, Yilmazer M, Orman A, Fenkci I . The effects of hormone therapy on pulmonary function tests in postmenopausal women. Maturitas. 2004; 49(3):221-7. DOI: 10.1016/j.maturitas.2004.01.009. View

12.

von Hafe P, Pina F, Perez A, Tavares M, Barros H . Visceral fat accumulation as a risk factor for prostate cancer. Obes Res. 2005; 12(12):1930-5. DOI: 10.1038/oby.2004.242. View

13.

Zamboni M, Mazzali G, Zoico E, Harris T, Meigs J, Di Francesco V . Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond). 2005; 29(9):1011-29. DOI: 10.1038/sj.ijo.0803005. View

14.

Lakoski S, Brosnihan B, Herrington D . Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial. Am Heart J. 2005; 150(5):907-11. DOI: 10.1016/j.ahj.2004.11.025. View

15.

Shaaban R, Kony S, Driss F, Leynaert B, Soussan D, Pin I . Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Respir Med. 2006; 100(12):2112-20. DOI: 10.1016/j.rmed.2006.03.027. View

16.

Parameswaran K, Todd D, Soth M . Altered respiratory physiology in obesity. Can Respir J. 2006; 13(4):203-10. PMC: 2683280. DOI: 10.1155/2006/834786. View

17.

Jones R, Nzekwu M . The effects of body mass index on lung volumes. Chest. 2006; 130(3):827-33. DOI: 10.1378/chest.130.3.827. View

18.

Ritchie S, Connell J . The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2006; 17(4):319-26. DOI: 10.1016/j.numecd.2006.07.005. View

19.

Fogarty A, Jones S, Britton J, Lewis S, McKeever T . Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax. 2007; 62(6):515-20. PMC: 2117221. DOI: 10.1136/thx.2006.066969. View

20.

Fox C, Massaro J, Hoffmann U, Pou K, Maurovich-Horvat P, Liu C . Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007; 116(1):39-48. DOI: 10.1161/CIRCULATIONAHA.106.675355. View